Hong Kong will be CMR Surgical’s gateway to the APAC region

Hong Kong will be catwalk for CMR Surgical in ACAP Region

  • VSMRI surgery to expand commercial deployment in the global surgical robotics market
  • Lrunning university hospitals in Hong Kong Chinese University of Hong Kong Medical Center and Gleneagles Hospital introduced Versius

Cambridge, United Kingdom. 28 April 2022 00:01 (GMT). CMR Surgical – the global surgical robotics company – today announced the introduction of the Versius® Surgical robotic system in Hong Kong at Chinese University of Hong Kong Medical Center (CUHKMC) and Gleneagles Hospital Hong Kong (GHK). CUHKMC was the first hospital in Hong Kong to introduce Versius, where it is used as part of a multidisciplinary robotics program, including general surgery and urology. At Gleneagles, Versius was first used in gynecological surgery, with plans to expand into general and other surgery as part of a multi-specialist programme.

With Versius, CUHKMC and GHK bring robot-assisted surgery directly to patients through state-of-the-art specialty centers, making surgical care accessible to more patients. With one of the longest life expectancies in the world, Hong Kong’s healthcare sector is a global leader in the use of high-tech equipment and surgical solutions for patients, representing a significant opportunity for Versius to be widely adopted in private and public hospitals. Asia will be a major growth engine for surgical robotics, where rapid digitization, growing demand and access to healthcare innovation will drive the adoption of healthcare technologies and innovations such as than Versius.

By Vegard NersethCEO of CMR Surgical said: “We have been looking forward to our launch in Hong Kong to provide the city’s world-leading healthcare system with access to pioneering new technology, I am delighted that we have entered such a robust and innovative market. Hong Kong will be our stepping stone to the rest of Asia as we prepare for further developments in APAC in due course and continue to place CMR Surgical on the global stage.

Dr Patrick Lau, Deputy Executive Director of the Hong Kong Trade Development Council, said: “Hong Kong is a leader in innovation and technology, including in healthcare. A new robotic system such as Versius that will have a positive impact on patients fits perfectly into this mould. We are delighted that CMR has chosen Hong Kong as the launching pad for the Asia-Pacific region, as we believe that Hong Kong offers biotechnology companies an ideal springboard from which to expand into fast-growing markets in mainland China, Asia and all over the world.

While the benefits of keyhole surgery for patients, such as shorter recovery time, less pain, and lower risk of surgical site infections, are well recognized, manual keyhole surgery Traditional surgery can be difficult to perform, resulting in many complex procedures being performed through open surgery.I Surgical robotic systems such as Versius offer increased accuracy, precision, and dexterity to surgeons, making it easier to perform more surgeries with keyhole surgery. The size, portability and versatility of Versius has made it popular with hospitals and surgeons around the world and has made Versius a cornerstone enabling more keyhole surgery.

Kin Cheung, Far East Manager by CMR Surgery mentioned: “The impact of the pandemic has been felt across healthcare systems around the world, and Hong Kong is no exception. With the vibrant spirit of Hong Kong as a guide, hospitals are looking for innovative solutions that help address this constraint while providing accessible technology options to their patients. We are excited to partner with leading hospitals, Chinese University of Hong Kong Medical Center and Gleneagles Hospital Hong Kong, to expand the benefits of robotic keyhole surgery. It’s great to see Versius stand out in Hong Kong and offer world-renowned surgeons a very different surgical robotic option. CMR will continue to expand its presence in Hong Kong to meet growing customer demand.

CMR has designed an agile business and pricing model to adapt to all global markets, increasing many people’s access to minimal access (keyhole) surgery. The value of innovation offered by Versius as cutting-edge robotic technology fits perfectly into an innovative and diverse healthcare ecosystem like that of Hong Kong and other markets in the APAC region.

To further invest in the market, CMR has partnered with a leading training facility, the CUHK Jockey Club Minimally Invasive Surgical Skills Center (Jockey Club MISSC), located within the Prince of Wales Hospital, to deliver a training and professional training for surgical teams. The introduction of Versius in Hong Kong follows CMR Surgical’s expansion into a number of markets across Europe, the Middle East, India and Australia, where the system is used to perform surgical procedures in a range of surgical specialties including gynecology, colorectal surgery, thoracic surgery, general surgery and urology.

– ENDS –

Media Contacts:

If you would like to see more, please contact CMR Surgical at:

Press officeCMR surgery
J +44(0) 1223 755801
E [email protected]

Notes to Editors:

The Versus® Surgical robotic system

Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room setup and integrates seamlessly into existing workflows, increasing the likelihood of minimal access robotic surgery (MAS). The compact, portable and modular design of Versius allows the surgeon to use only the number of arms needed for a given procedure.

Biomimicking the human arm, Versius offers surgeons the choice of optimized port placement, along with the dexterity and precision of small, full-wrist instruments. With 3D HD vision, easy-to-adopt instrument control, and a choice of ergonomic working positions, the Open Surgeon Console has the potential to reduce stress and fatigue and enables clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that MAS robotics brings.

But it’s more than just a robot. Versius captures meaningful data with its broader digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and the CMR Clinical Registry, Versius unlocks a wealth of information to improve surgical care.

About CMR Surgical Limited

CMR Surgical (CMR) is a global medical device company dedicated to transforming surgery with Versius®a new generation surgical robot.

Based in Cambridge, UK, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make minimal access robotic surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.

Founded in 2014, CMR Surgical is a limited company backed by international shareholders.


I EUR Urol, Journal of Endourology, BMJ

Christine E. Phillips